82 related articles for article (PubMed ID: 11433540)
1. On-line coupling of hollow fiber membranes with electrospray ionization mass spectrometry for continuous affinity selection, concentration and identification of small-molecule libraries.
Jiang Y; Lee CS
J Mass Spectrom; 2001 Jun; 36(6):664-9. PubMed ID: 11433540
[TBL] [Abstract][Full Text] [Related]
2. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
[TBL] [Abstract][Full Text] [Related]
3. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
Benkestock K; Edlund PO; Roeraade J
Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometry and combinatorial chemistry: a short outline.
Triolo A; Altamura M; Cardinali F; Sisto A; Maggi CA
J Mass Spectrom; 2001 Dec; 36(12):1249-59. PubMed ID: 11754116
[TBL] [Abstract][Full Text] [Related]
5. Approaches towards the automated interpretation and prediction of electrospray tandem mass spectra of non-peptidic combinatorial compounds.
Klagkou K; Pullen F; Harrison M; Organ A; Firth A; Langley GJ
Rapid Commun Mass Spectrom; 2003; 17(11):1163-8. PubMed ID: 12772272
[TBL] [Abstract][Full Text] [Related]
6. Immunoaffinity Ultrafiltration with Ion Spray HPLC/MS for Screening Small-Molecule Libraries.
Wieboldt R; Zweigenbaum J; Henion J
Anal Chem; 1997 May; 69(9):1683-91. PubMed ID: 21639291
[TBL] [Abstract][Full Text] [Related]
7. On-line microdialysis for enhanced resolution and sensitivity during electrospray mass spectrometry of non-covalent complexes and competitive binding studies.
Benkestock K; Edlund PO; Roeraade J
Rapid Commun Mass Spectrom; 2002; 16(21):2054-9. PubMed ID: 12391580
[TBL] [Abstract][Full Text] [Related]
8. High-throughput solution-based medicinal library screening against human serum albumin.
Flarakos J; Morand KL; Vouros P
Anal Chem; 2005 Mar; 77(5):1345-53. PubMed ID: 15732917
[TBL] [Abstract][Full Text] [Related]
9. Rapid methods for screening low molecular mass compounds non-covalently bound to proteins using size exclusion and mass spectrometry applied to inhibitors of human cytomegalovirus protease.
Siegel MM; Tabei K; Bebernitz GA; Baum EZ
J Mass Spectrom; 1998 Mar; 33(3):264-73. PubMed ID: 9538525
[TBL] [Abstract][Full Text] [Related]
10. On-line hollow-fiber flow field-flow fractionation-electrospray ionization/time-of-flight mass spectrometry of intact proteins.
Reschiglian P; Zattoni A; Roda B; Cinque L; Parisi D; Roda A; Dal Piaz F; Moon MH; Min BR
Anal Chem; 2005 Jan; 77(1):47-56. PubMed ID: 15623277
[TBL] [Abstract][Full Text] [Related]
11. A facile microdialysis interface for on-line desalting and identification of proteins by nano-electrospray ionization mass spectrometry.
Sun L; Duan J; Tao D; Liang Z; Zhang W; Zhang L; Zhang Y
Rapid Commun Mass Spectrom; 2008 Aug; 22(15):2391-7. PubMed ID: 18613004
[TBL] [Abstract][Full Text] [Related]
12. Affinity classification of kinase inhibitors by mass spectrometric methods and validation using standard IC(50) measurements.
Jecklin MC; Touboul D; Jain R; Toole EN; Tallarico J; Drueckes P; Ramage P; Zenobi R
Anal Chem; 2009 Jan; 81(1):408-19. PubMed ID: 19067573
[TBL] [Abstract][Full Text] [Related]
13. Frontal affinity chromatography combined on-line with mass spectrometry: a tool for the binding study of different epidermal growth factor receptor inhibitors.
Zhu L; Chen L; Luo H; Xu X
Anal Chem; 2003 Dec; 75(23):6388-93. PubMed ID: 14640705
[TBL] [Abstract][Full Text] [Related]
14. Applications of mass spectrometry in early stages of target based drug discovery.
Deng G; Sanyal G
J Pharm Biomed Anal; 2006 Feb; 40(3):528-38. PubMed ID: 16256286
[TBL] [Abstract][Full Text] [Related]
15. Integration of mass spectrometry into early-phase discovery and development of central nervous system agents.
Prokai L; Zharikova A; Janáky T; Li X; Braddy AC; Perjési P; Matveeva L; Powell DH; Prokai-Tatrai K
J Mass Spectrom; 2001 Nov; 36(11):1211-9. PubMed ID: 11747117
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening of protein binding by equilibrium dialysis combined with liquid chromatography and mass spectrometry.
Wan H; Rehngren M
J Chromatogr A; 2006 Jan; 1102(1-2):125-34. PubMed ID: 16266710
[TBL] [Abstract][Full Text] [Related]
17. Drug screening of pharmaceutical discovery compounds by micro-size exclusion chromatography/mass spectrometry.
Wabnitz PA; Loo JA
Rapid Commun Mass Spectrom; 2002; 16(2):85-91. PubMed ID: 11754252
[TBL] [Abstract][Full Text] [Related]
18. Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes.
Hofstadler SA; Sannes-Lowery KA
Nat Rev Drug Discov; 2006 Jul; 5(7):585-95. PubMed ID: 16816839
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
